Agronomics - Fermenting growth and commercial viability
Agronomics (ANIC) invests in cellular agriculture companies. This report provides an update on our January 2022 initiation note and March 2022 update, following the announcement of ANIC’s Q2 NAV and some exciting new portfolio investments. These investments mark a shift in focus, in favour of companies such as precision fermentation contract manufacturer Liberation Labs and All G Foods, which appear to offer greater near-term commercial potential. ANIC’s performance since inception in 2019 has been positive, with an NAV total return of 80% over this period. And we share the company’s view that there is significant potential for further NAV uplifts over time, as and when the company’s greater focus on nearer-term income pays off, and its longer-standing portfolio holdings make further progress towards financial viability.Port Erin BioPharma Investments is engaged in investing in the biotechnology and biopharmaceutical sector.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.